Occult hepatitis B virus infection in pregnant woman and its clinical implication

Liver International

Volumn 28, Issue 5, 2008, Pages 667-674

  Kwon, Chang Il ^a   Hwang, Seong Gyu ^a   Shin, Seung Ju ^a   Chang, Sung Woon ^a   Kim, Su Youn ^a   Ko, Kwang Hyun ^a   Hong, Sung Pyo ^a   Park, Pil Won ^a   Rim, Kyu Sung ^a   Kang, Myung Seo ^a   Chung, Hyun Jae ^b   Hong, Sun Pyo ^b  

^a CHA University   (South Korea)

^b GeneMatrix Inc   (South Korea)

Author keywords

Chronic hepatitis B; COBAS; Genotyping analysis; Hepatitis B virus; Occult HBV infection; Pregnancy; Sequencing analysis; TaqMan; Vertical transmission

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DNA POLYMERASE; HEMOGLOBIN; HEPATITIS B CORE ANTIBODY; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; HEPATITIS B(E) ANTIGEN; VIRUS DNA;

ADULT; ANAMNESIS; ANTIGEN DETECTION; ARTICLE; BLOOD ANALYSIS; BODY HEIGHT; BODY WEIGHT; CHEMOLUMINESCENCE; CONTROLLED STUDY; DNA DETERMINATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; FALSE POSITIVE RESULT; FEMALE; GENOTYPE; GESTATION PERIOD; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RESEARCH; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREGNANCY; PREVALENCE; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS; UMBILICAL CORD BLOOD; VERTICAL TRANSMISSION; VIRUS IDENTIFICATION; VIRUS TRANSMISSION;

ADULT; DISEASE TRANSMISSION, VERTICAL; DNA, VIRAL; FEMALE; GENE PRODUCTS, POL; HEPATITIS B; HUMANS; INFANT, NEWBORN; KOREA; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREVALENCE; PROSPECTIVE STUDIES; SEQUENCE ANALYSIS, DNA;

EID: 42149168420     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01699.x     Document Type: Article

References (22)

1. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733-45.
2. Ahn SH, Park YN, Park JY, et al. Long-term clinical histological outcomes in patients with spontaneous hepatitis B surface antigen seroclearance. J Hepatol 2005; 42: 188-94.
3. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9: 243-57.
4. Brechot C, Thiers V, Kremsdorf D, et al. Persistent hepatitis B virus infection in subjects without hepatitis B surface antige: Clinically significant or purely "occult"? Hepatology 2001; 34: 194-203.
5. Chen CJ. Time-dependent events in natural history of occult hepatitis B virus infection: The importance of population-based long-term follow-up study with repeated measurements. J Hepatol 2005; 42: 438-40.
6. Minuk GY, Sun DF, Uhanova J, et al. Occult hepatitis B virus infection in a North American community-based population. J Hepatol 2005; 42: 480-5.
7. Torbenson M, Thomas DL. Occult hepatitis B. Lancet Infect Dis 2002; 2: 479-86.
8. Saito T, Shinzawa H, Uchida T, et al. Quantitative DNA analysis of low-level hepatitis B viremia in two patients with serologically negative chronic hepatitis B. J Med Virol 1999; 58: 325-31.
9. Coffin CS, Michalak TI. Persistence of infectious hepadnavirus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999; 104: 203-12.
10. Lopez VA, Bourne EJ, Lutz MW, Condreay LD. Assessment of the COBAS Amplicor HBV Monitor Test for quantitation of serum hepatitis B virus DNA levels. J Clin Microbiol 2002; 40: 1972-6.
11. Yeon JE, Yoo W, Hong SP, et al. Resistance to Adefovir Dipivoxil (ADV) in Lamivudine-resistant chronic hepatitis B Patients treated with ADV. Gut 2006; 55: 1488-95.
12. Chayama K, Suzuki Y, Kobayashi M, et al. Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology 1998; 27: 1711-6.
13. Rozanov M, Plikat U, Chappey C, Kochergin A, Tatusova T. A web-based genotyping resource for viral sequences. Nucleic Acids Res 2004; 32: W654-9.
14. Felsenstein J. 1993. PHYLIP Inference Package version 3.5. Seattle, USA: Department of Genetics, University of Washington.
15. Allice T, Cerutti F, Pittaluga F, et al. COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: A novel automated real-time PCR assay for quantification of HBV DNA in plasma. J Clin Microbiol 2007; 45: 828-34.
16. Hoofnagle JH, Seef LB, Bales ZB, Zimmerman HJ. The type B hepatitis after transfusion with blood containing antibody to hepatitis B core antigen. N Engl J Med 1978; 298: 1379-83.
17. Kaneko S, Miller RH, Feinstone SM, et al. Detection of serum hepatitis B virus DNA in patients with chronic hepatitis using the polymerase chain reaction assay. Proc Natl Acad Aci USA 1989; 86: 312-6.
18. Thiers V, Nakajima E, Kremsdorf D, et al. Transmission of hepatitis B from hepatitis-B-seronegative subjects. Lancet 1988; 2: 1273-6.
19. Loeb KR, Jerome KR, Goddard J, Huang M, Cent A, Corey L. High-throughput quantitative analysis of hepatitis B virus DNA in serum using the TaqMan fluorogenic detection system. Hepatology 2000; 32: 626-9.
20. Gordillo RM, Gutierrez J, Casal M. Evaluation of the COBAS TaqMan 48 real-time PCR system for quantitation of hepatitis B virus DNA. J Clin Microbiol 2005; 43: 3504-7.
21. Namgyal P. Impact of hepatitis B immunization, Europe and world. J Hepatol 2003; 39: S77-82.
22. Kang HS, Song BC, Ji CX, Kim SY, Kim SK. Serologic markers of hepatitis B virus in pregnant women in Jeju Island. Korean J Hepatol 2004; 10: 191-6.